POU5F1 and non-small cell lung carcinoma: For instance, in non-small cell lung cancer (NSCLC), PAK1 enhances β-catenin-mediated cancer stemness, stabilizing markers such as OCT4 and SOX2 and driving tumor aggressiveness and chemoresistance.